Switch theme
Sign up to access all valuation multiples
Chularat Hospital PCL operates hospitals and clinics in Thailand. The company operates through several branches of clinics and hospitals. The Group operates a private hospital business which is one business segment. It has only one geographical segment as the business operates only in Thailand.
1986
n/a
LTM Revenue $258M
LTM EBITDA $52.9M
$505M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Chularat Hospital has a last 12-month revenue (LTM) of $258M and a last 12-month EBITDA of $52.9M.
In the most recent fiscal year, Chularat Hospital achieved revenue of $251M and an EBITDA of $54.1M.
Chularat Hospital expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Chularat Hospital valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $258M | XXX | $251M | XXX | XXX | XXX |
| Gross Profit | $74.4M | XXX | $66.1M | XXX | XXX | XXX |
| Gross Margin | 29% | XXX | 26% | XXX | XXX | XXX |
| EBITDA | $52.9M | XXX | $54.1M | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 22% | XXX | XXX | XXX |
| EBIT | $37.5M | XXX | $39.2M | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 16% | XXX | XXX | XXX |
| Net Profit | $31.6M | XXX | $29.4M | XXX | XXX | XXX |
| Net Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Chularat Hospital's stock price is THB 2 (or $0).
Chularat Hospital has current market cap of THB 17.9B (or $546M), and EV of THB 16.6B (or $505M).
See Chularat Hospital trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $505M | $546M | XXX | XXX | XXX | XXX | $0.00 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Chularat Hospital has market cap of $546M and EV of $505M.
Chularat Hospital's trades at 2.0x EV/Revenue multiple, and 9.3x EV/EBITDA.
Equity research analysts estimate Chularat Hospital's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Chularat Hospital has a P/E ratio of 17.3x.
See valuation multiples for Chularat Hospital and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $546M | XXX | $546M | XXX | XXX | XXX |
| EV (current) | $505M | XXX | $505M | XXX | XXX | XXX |
| EV/Revenue | 2.0x | XXX | 2.0x | XXX | XXX | XXX |
| EV/EBITDA | 9.6x | XXX | 9.3x | XXX | XXX | XXX |
| EV/EBIT | 13.5x | XXX | 12.9x | XXX | XXX | XXX |
| EV/Gross Profit | 6.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 17.3x | XXX | 18.6x | XXX | XXX | XXX |
| EV/FCF | 16.2x | XXX | 14.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialChularat Hospital's last 12 month revenue growth is 8%
Chularat Hospital's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Chularat Hospital's rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Chularat Hospital's rule of X is 39% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Chularat Hospital and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 22% | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | 2% | XXX | XXX | XXX |
| Rule of 40 | 31% | XXX | 29% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 39% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 11% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Chularat Hospital acquired XXX companies to date.
Last acquisition by Chularat Hospital was XXXXXXXX, XXXXX XXXXX XXXXXX . Chularat Hospital acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Chularat Hospital founded? | Chularat Hospital was founded in 1986. |
| Where is Chularat Hospital headquartered? | Chularat Hospital is headquartered in Thailand. |
| Who is the CEO of Chularat Hospital? | Chularat Hospital's CEO is Dr. Jedsada Chokdamrongsuk. |
| Is Chularat Hospital publicy listed? | Yes, Chularat Hospital is a public company listed on BKK. |
| What is the stock symbol of Chularat Hospital? | Chularat Hospital trades under CHG ticker. |
| When did Chularat Hospital go public? | Chularat Hospital went public in 2013. |
| Who are competitors of Chularat Hospital? | Similar companies to Chularat Hospital include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Chularat Hospital? | Chularat Hospital's current market cap is $546M |
| What is the current revenue of Chularat Hospital? | Chularat Hospital's last 12 months revenue is $258M. |
| What is the current revenue growth of Chularat Hospital? | Chularat Hospital revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Chularat Hospital? | Current revenue multiple of Chularat Hospital is 2.0x. |
| Is Chularat Hospital profitable? | Yes, Chularat Hospital is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Chularat Hospital? | Chularat Hospital's last 12 months EBITDA is $52.9M. |
| What is Chularat Hospital's EBITDA margin? | Chularat Hospital's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Chularat Hospital? | Current EBITDA multiple of Chularat Hospital is 9.6x. |
| What is the current FCF of Chularat Hospital? | Chularat Hospital's last 12 months FCF is $31.2M. |
| What is Chularat Hospital's FCF margin? | Chularat Hospital's last 12 months FCF margin is 12%. |
| What is the current EV/FCF multiple of Chularat Hospital? | Current FCF multiple of Chularat Hospital is 16.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
